Comparison of human memory CD8 T cell responses to adenoviral early and late proteins in peripheral blood and lymphoid tissue.
Comparison of human memory CD8 T cell responses to adenoviral early and late proteins in peripheral blood and lymphoid tissue.
复制标题
DOI:
10.1371/journal.pone.0020068
复制
发表时间:
2011
期刊:
影响因子:
3.7
通讯作者:
Flomenberg P
中科院分区:
文献类型:
--
作者:
Joshi A;Zhao B;Romanowski C;Rosen D;Flomenberg P
Treatment of invasive adenovirus (Ad) disease in hematopoietic stem cell transplant (SCT) recipients with capsid protein hexon-specific donor T cells is under investigation. We propose that cytotoxic T cells (CTLs) targeted to the late protein hexon may be inefficient in vivo because the early Ad protein E3-19K downregulates HLA class I antigens in infected cells. In this study, CD8+ T cells targeted to highly conserved HLA A2-restricted epitopes from the early regulatory protein DNA polymerase (P-977) and late protein hexon (H-892) were compared in peripheral blood (PB) and tonsils of naturally infected adults. In tonsils, epitope-specific pentamers detected a significantly higher frequency of P-977+CD8+ T cells compared to H-892+CD8+ T cells; this trend was reversed in PB. Tonsil epitope-specific CD8+ T cells expressed IFN-γ and IL-2 but not perforin or TNF-α, whereas PB T cells were positive for IFN-γ, TNF-α, and perforin. Tonsil epitope-specific T cells expressed lymphoid homing marker CCR7 and exhibited lower levels of the activation marker CD25 but higher proliferative potential than PB T cells. Finally, in parallel with the kinetics of mRNA expression, P-977-specific CTLs lysed targets as early as 8 hrs post infection. In contrast, H-892-specific CTLs did not kill unless infected fibroblasts were pretreated with IFN-γ to up regulate HLA class I antigens, and cytotoxicity was delayed until 16–24 hours. These data show that, in contrast to hexon CTLs, central memory type DNA polymerase CTLs dominate the lymphoid compartment and kill fibroblasts earlier after infection without requiring exogenous IFN-γ. Thus, use of CTLs targeted to both early and late Ad proteins may improve the efficacy of immunotherapy for life-threatening Ad disease in SCT recipients.
登录
查看更多内容
DOI:
10.1073/pnas.0503726102
发表时间:
2005-07-05
影响因子:
11.1
作者:
Klebanoff, CA;Gattinoni, L;Restifo, NP
通讯作者:
Restifo, NP
影响因子:
15.3
作者:
Kim, Taeg S.;Hufford, Matthew M.;Braciale, Thomas J.
通讯作者:
Braciale, Thomas J.
影响因子:
5.4
作者:
BHAT, BM;WOLD, WSM
通讯作者:
WOLD, WSM
影响因子:
11.8
作者:
La Rosa, AM;Champlin, RE;Whimbey, E
通讯作者:
Whimbey, E
DOI:
10.1084/jem.20050227
发表时间:
2005-09-05
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Jelley-Gibbs DM;Brown DM;Dibble JP;Haynes L;Eaton SM;Swain SL
通讯作者:
Swain SL